
浏览全部资源
扫码关注微信
1.河南中医药大学第一附属医院儿科医院,郑州 450099
2.河南中医药大学儿科医学院,郑州 450099
3.南京中医药大学宿迁附属医院儿科,江苏 宿迁 223800
博士研究生。研究方向:中医药防治小儿呼吸系统疾病。E-mail:renmingyuexs@126.com
教授,主任医师,博士生导师,博士。研究方向:中医药防治小儿呼吸系统疾病。E-mail:songgh123@126.com
收稿:2026-01-15,
修回:2026-06-16,
录用:2026-06-17,
纸质出版:2026-07-15
移动端阅览
任明月,宋桂华,王婷婷,等.加味小青龙汤联合BMSCs对寒性哮喘大鼠鼻-肺-肠黏膜免疫的影响及机制[J].中国药房,2026,37(13):1691-1696.
REN Mingyue,SONG Guihua,WANG Tingting,et al.Effects and mechanisms of modified Xiaoqinglong decoction combined with BMSCs on nasal-pulmonary-intestinal mucosal immunity in cold asthma rats[J].ZHONGGUO YAOFANG,2026,37(13):1691-1696.
任明月,宋桂华,王婷婷,等.加味小青龙汤联合BMSCs对寒性哮喘大鼠鼻-肺-肠黏膜免疫的影响及机制[J].中国药房,2026,37(13):1691-1696. DOI: 10.6039/j.issn.1001-0408.2026.13.06.
REN Mingyue,SONG Guihua,WANG Tingting,et al.Effects and mechanisms of modified Xiaoqinglong decoction combined with BMSCs on nasal-pulmonary-intestinal mucosal immunity in cold asthma rats[J].ZHONGGUO YAOFANG,2026,37(13):1691-1696. DOI: 10.6039/j.issn.1001-0408.2026.13.06.
目的
2
探讨加味小青龙汤联合骨髓间充质干细胞(BMSCs)对寒性哮喘大鼠鼻-肺-肠黏膜免疫的影响及机制。
方法
2
将SD大鼠随机分为空白组、模型组、BMSCs组、BMSCs+加味小青龙汤(6.39 g/kg)组、BMSCs+地塞米松(0.125 mg/kg)组,每组10只。采用卵清蛋白联合氢氧化铝致敏及雾化激发,并结合空调冷风吹袭建立寒性哮喘大鼠模型。初次雾化激发前1 h,除空白组和模型组外,其余各组大鼠尾静脉注射BMSCs混悬液;实验第15天起,各组大鼠灌胃相应药液/生理盐水,每日1次,连续7 d。末次给药后,评估大鼠哮喘行为学和肺组织病理学形态变化,检测鼻咽冲洗液、肺泡灌洗液(BALF)和肠黏液中白细胞介素6(IL-6)、IL-10水平;检测鼻、肺、肠组织中磷脂酰肌醇3-激酶(PI3K)/蛋白激酶B(Akt)信号通路相关蛋白表达水平。
结果
2
与空白组比较,模型组大鼠哮喘行为学评分、肺组织损伤程度评分,鼻咽冲洗液、BALF和肠黏液中IL-6水平,鼻、肺、肠组织中PI3K蛋白表达水平和Akt蛋白磷酸化水平均显著升高(
P
<0.05);鼻咽冲洗液、BALF和肠黏液中IL-10水平均显著降低(
P
<0.05);肺泡萎缩、塌陷甚至融合,支气管管壁平滑肌异常增生肥厚,可见大量炎症细胞浸润。与模型组比较,BMSCs组、BMSCs+加味小青龙汤组、BMSCs+地塞米松组上述大部分定量指标均显著逆转(
P
<0.05);肺组织病理学损伤均明显减轻。与BMSCs组比较,BMSCs+加味小青龙汤组上述大部分定量指标均进一步改善(
P
<0.05)。
结论
2
加味小青龙汤联合BMSCs能有效改善寒性哮喘大鼠鼻-肺-肠黏膜免疫,缓解哮喘症状,其作用机制可能与抑制PI3K/Akt信号通路激活有关。
OBJECTIVE
2
To investigate the effects and mechanism of modified Xiaoqinglong decoction combined with bone marrow mesenchymal stem cells (BMSCs) on nasal-pulmonary-intestinal mucosal immunity in rats with cold asthma.
METHODS
2
SD rats were randomly divided into blank group, model group, BMSCs group, BMSCs+modified Xiaoqinglong decoction (6.39 g/kg) group, and BMSCs+dexamethasone (0.125 mg/kg) group, with 10 rats in each group. The cold asthma rat model was established by sensitization and atomization challenge with ovalbumin combined with aluminum hydroxide, together with cold air stimulation from air conditioners. One hour before the initial atomization challenge, rats in all groups except the blank group and model group were injected with BMSCs suspension via the tail vein. Starting from the 15th day of the experiment, rats in each group were intragastrically administered corresponding liquid medicine or normal saline once a day for 7 consecutive days. After the last administration, the asthmatic behavioral changes and pathological morphological changes of lung tissues in rats were evaluated. The levels of interleukin-6 (IL-6) and IL-10 in nasopharyngeal lavage fluid, bronchoalveolar lavage fluid (BALF) and intestinal mucus were detected. The expression levels of proteins related to the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway in nasal, lung and intestinal tissues were determined.
RESULTS
2
Compared with the blank group, the asthmatic behavioral score, lung tissue injury score, IL-6 levels in nasopharyngeal lavage fluid, BALF and intestinal mucus, PI3K protein expression and Akt phosphorylation levels in nasal, lung and intestinal tissues of rats in the model group were significantly increased (
P
<0.05); the IL-10 levels in nasopharyngeal lavage fluid, BALF and intestinal mucus were significantly decreased (
P
<0.05). Alveolar atrophy, collapse and even fusion, abnormal hyperplasia and hypertrophy of bronchial smooth muscle, and massive inflammatory cell infiltration were observed. Compared with the model group, most of the above quantitative indicators in the BMSCs group, BMSCs+modified Xiaoqinglong decoction group and BMSCs+dexamethasone group were significantly reversed (
P
<0.05), and pathological injuries of lung tissues were markedly alleviated. Compared with the BMSCs group, most of the above quantitative indicators were further improved in the BMSCs+modified Xiaoqinglong decoction group (
P
<0.05).
CONCLUSIONS
2
Modified Xiaoqinglong decoction combined with BMSCs can effectively improve nasal-pulmonary-intestinal mucosal immunity and relieve asthmatic symptoms in cold asthma rats, and its mechanism may be related to inhibiting the activation of the PI3K/Akt signaling pathway.
Batard T , Taillé C , Guilleminault L , et al . Allergen immunotherapy for the prevention and treatment of asthma [J ] . Clin Exp Allergy , 2025 , 55 ( 2 ): 111 - 141 .
Yu J R , Xu L , Han A Z , et al . The epidemiology of asthma in Mainland China:a systematic review and meta-analysis [J ] . BMC Public Health , 2024 , 24 ( 1 ): 2888 .
Chen S H , Gao J Q , Zhang T Y . From mesenchymal stem cells to their extracellular vesicles:progress and prospects for asthma therapy [J ] . Asian J Pharm Sci , 2024 , 19 ( 4 ): 100942 .
Huang S , Li Y Y , Zeng J Q , et al . Mesenchymal stem/stromal cells in asthma therapy:mechanisms and strategies for enhancement [J ] . Cell Transplant , 2023 , 32 : 9636897231180128 .
楼招欢 , 赵华军 , 吕圭源 . “肺与大肠相表里”的黏膜免疫调节机制及中药干预作用研究进展 [J ] . 浙江大学学报(医学版) , 2020 , 49 ( 6 ): 665 - 678 .
徐瀛濂 , 田静 , 张翔 , 等 . 气道上皮细胞在哮喘发病机制中的作用研究进展 [J ] . 上海交通大学学报(医学版) , 2023 , 43 ( 5 ): 619 - 623 .
宋桂华 , 彭明浩 , 张岩 , 等 . 加味小青龙汤治疗支气管哮喘慢性持续期临床疗效及对IL-6、IL-10、SIgA的影响 [J ] . 中华中医药学刊 , 2020 , 38 ( 9 ): 5 - 9 .
宋桂华 , 赵慧颖 , 于素平 , 等 . 加味小青龙汤对哮喘大鼠肺-肠黏膜免疫影响及相关作用机制研究 [J ] . 时珍国医国药 , 2023 , 34 ( 3 ): 542 - 545 .
任佳营 , 宋桂华 , 孙萌萌 , 等 . 加味小青龙汤影响Treg/Th17细胞失衡改善小鼠哮喘的机制研究 [J ] . 时珍国医国药 , 2024 , 35 ( 3 ): 532 - 537 .
Tynecka M , Moniuszko M , Eljaszewicz A . Old friends with unexploited perspectives:current advances in mesenchymal stem cell-based therapies in asthma [J ] . Stem Cell Rev Rep , 2021 , 17 ( 4 ): 1323 - 1342 .
Wang K , Cao X M , Yang L , et al . Modulating Th1/Th2 drift in asthma-related immune inflammation by enhancing bone mesenchymal stem cell homing through targeted inhibition of the Notch1/Jagged1 signaling pathway [J ] . Int Immunopharmacol , 2024 , 130 : 111713 .
Choi J Y , Hur J , Jeon S , et al . Effects of human adipose tissue- and bone marrow-derived mesenchymal stem cells on airway inflammation and remodeling in a murine model of chronic asthma [J ] . Sci Rep , 2022 , 12 ( 1 ): 12032 .
Li X , Zhan J H , Hou Y , et al . Coenzyme Q10 regulation of apoptosis and oxidative stress in H 2 O 2 induced BMSC death by modulating the Nrf-2/NQO-1 signaling pathway and its application in a model of spinal cord injury [J ] . Oxid Med Cell Longev , 2019 , 2019 : 6493081 .
邓亚胜 , 范燕萍 , 李汶玥 , 等 . 中医药调控PI3K/Akt信号通路干预哮喘的研究进展 [J ] . 中国实验方剂学杂志 , 2025 , 31 ( 17 ): 262 - 275 .
王心恒 , 邵小涵 , 李童童 , 等 . 平喘宁方通过调控HMGB1/Beclin-1轴介导的自噬改善患寒哮证大鼠的气道炎症 [J ] . 南方医科大学学报 , 2025 , 45 ( 6 ): 1153 - 1162 .
颜维孝 , 宋亚娣 , 李娟 . 培菲康通过下调TLR4/NF-κB信号减轻哮喘小鼠气道炎症及气道重塑 [J ] . 免疫学杂志 , 2023 , 39 ( 6 ): 478 - 486 .
杨盼盼 , 刘燕 , 李晨阳 , 等 . 基于NLRP3/caspase-1/IL-1β信号通路探讨胀果甘草总黄酮对哮喘小鼠的保护作用及机制 [J/OL ] . 中国药理学通报 , 2026 : 1 - 12 . https://link.cnki.net/urlid/34.1086.r.20251216.1715.004 https://link.cnki.net/urlid/34.1086.r.20251216.1715.004 .
秦慧娟 . 基于哮喘黏膜免疫研究“肺开窍于鼻”,“肺与大肠相表里”理论 [D ] . 乌鲁木齐 : 新疆医科大学 , 2009 : 27 .
徐子骞 , 朱星星 , 孟野松 , 等 . 肠道菌群与哮喘研究进展 [J ] . 海军军医大学学报 , 2025 , 46 ( 11 ): 1467 - 1475 .
张晓娜 , 史锁芳 . 基于 “肺合大肠” 理论探讨肠道微生态、黏膜免疫与支气管哮喘之间的相关性 [J ] . 中华中医药杂志 , 2022 , 37 ( 11 ): 6394 - 6397 .
孙梦迪 , 孙志运 , 王克婧 , 等 . 中药复方调控肺-肠轴治疗呼吸系统疾病的研究进展 [J ] . 药物评价研究 , 2025 , 48 ( 9 ): 2689 - 2702 .
Souza L S , Ferreira-Junior A S , Estella P C , et al . Bacte- riome signature in SARS-CoV-2-infected patients correlates with increased gut permeability and systemic inflammatory cytokines [J ] . Microorganisms , 2025 , 13 ( 6 ): 1407 .
Branchett W J , Saraiva M , O’Garra A . Regulation of inflammation by interleukin-10 in the intestinal and respiratory mucosa [J ] . Curr Opin Immunol , 2024 , 91 : 102495 .
陈奕帆 , 王雨欣 , 顾雨菲 , 等 . 支气管哮喘气道炎症损伤中免疫失衡的研究进展 [J ] . 中国医科大学学报 , 2023 , 52 ( 4 ): 371 - 374 .
郑朵 , 杨丽娟 , 林娜 . 白介素-10基因启动子rs1800896和rs1800871位点基因多态性与黑衣壮儿童支气管哮喘关系的研究 [J ] . 右江医学 , 2023 , 51 ( 6 ): 519 - 525 .
Hoxhaj G , Manning B D . The PI3K-AKT network at the interface of oncogenic signaling and cancer metabolism [J ] . Nat Rev Cancer , 2020 , 20 ( 2 ): 74 - 88 .
蔡丽鑫 . PI3K/AKT信号通路在支气管哮喘的研究进展及中医药干预现状 [J ] . 中医学 , 2023 , 12 ( 10 ): 2819 - 2825 .
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621